SPARCL1 and pulmonary hypertension: Sparc contributes to angiogenesis, with both pro-angiogenic and anti-angiogenic effect reported,57 while Sparcl1 has recently been reported as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension.58